The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Psychiatric Practice & Managed CareFull Access

How Is Part D Working for You? APA Wants to Know

Published Online:https://doi.org/10.1176/pn.43.9.0044b

Irvin L. “Sam” Muszynski, J.D., director of APA's Office of Healthcare Systems and Financing (OHSF), is concerned that APA members are being pressured into prescribing drugs for their Medicare patients that they think are less than optimal because of access restrictions imposed by Part D drug plans. He wants APA members to know that OHSF has been very successful in working with the Centers for Medicare and Medicaid Services (CMS) to ensure that patients with Part D coverage get the medications they require. Since Part D prescription drug plans are supposed to provide access to all or substantially all antidepressants, antipsychotics, and anticonvulsants, APA members who have patients encountering problems with access to drugs in these categories should contact APA's Managed Care Help Line at (800) 343-4671.

The only way APA can successfully ask that Medicare make necessary systemic changes to Part D, noted Muszynski, is if OHSF can provide CMS with data showing those parts of the program that are not working. So please let us hear from you. Not only will your patients benefit, but so will the patients of your colleagues.